Saturday 17 October 2026 Export MDGL’s income statement to Excel — free account

Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $958.4 million, up 432.1% from fiscal 2024. In the quarter to June 2026, revenue grew 71.2%, EPS fell 32.9%, free cash flow grew 140.5% and total debt rose 187.9%, each against the same quarter a year earlier.

449.74 10.07 −2.19%

Follow MDGL

Alert me

Market cap: $10.6B
P/E: 0.0×
Fwd P/E: −71.3×
Dividend yield: —
F-score: n/a
Altman Z: 10.48
Beneish M: 0.50
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	12.19	13.42	13.63	13.92
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	670.81	(90.77)	(97.89)	129.14
P/B ratio Full definition →	29.88	27.96	21.68	16.48
Price to Tangible BV Full definition →	30.30	28.34	21.95	16.68
EV/Sales Full definition →	11.80	13.00	12.95	12.88
EV/EBITDA Full definition →	0.00	0.00	0.00	0.00
EV/Operating CF Full definition →	(76.63)	(54.90)	(65.50)	(59.39)
EV/FCF Full definition →	(72.40)	(53.41)	(64.00)	(57.61)
Quick Ratio Full definition →	2.76	2.97	3.62	3.14
Current Ratio Full definition →	3.20	3.50	4.01	3.44
Net Debt/EBITDA Full definition →	9.09	5.22	11.34	6.94
Debt/Assets Full definition →	27.38%	27.73%	26.98%	24.94%
Debt/Equity Full definition →	0.65	0.63	0.56	0.54
Asset Turnover Full definition →	1.14	1.02	0.83	0.61
Operating CF/Net income Full definition →	(0.40)	1.77	2.28	(0.70)
Capex/Depreciation Full definition →	(2.85)	(3.10)	0.16	(1.72)
Interest Coverage Full definition →	(7.09)	(11.86)	(7.18)	(15.30)
Research and Development Expense of Revenue Full definition →	25.03%	34.91%	36.21%	60.57%
Selling, General and Administrative Expense of Revenue Full definition →	79.44%	86.25%	74.74%	72.80%
Intangible Assets out of Total Assets Full definition →	0.01	0.01	0.01	0.01
Share Based Compensation of Revenue Full definition →	9.71%	10.93%	8.03%	9.14%
Graham Net Nets Full definition →	0.03	0.03	0.05	0.06
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(2.40%)	(2.37%)	(2.02%)	(2.59%)
Free Cash Flow Yield Full definition →	(1.34%)	(1.81%)	(1.48%)	(1.61%)
Revenue per Share Full definition →	12.50	10.72	14.31	12.78
Operating CF per Share Full definition →	0.80	(5.77)	(5.95)	3.55
Capex per Share Full definition →	(0.15)	(0.13)	0.02	(0.17)
Free Cash Flow per Share Full definition →	0.65	(5.90)	(5.93)	3.38
Cash per Share Full definition →	28.78	28.17	44.07	49.58
Shareholders Equity per Share Full definition →	17.97	18.72	26.87	27.83
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	17.97	18.72	26.87	27.83
Free Cash Flow Full definition →	19.08	(171.28)	(133.07)	75.99
Working Capital Full definition →	824.98	844.05	935.48	955.27
Capital Expenditures Full definition →	(4.25)	(3.85)	0.39	(3.86)
Net Current Asset Value Full definition →	478.26	498.43	588.87	609.96
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.01	0.01	0.00	0.01
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	135.77	124.39	94.15	71.87
Average Payables Full definition →	36.24	51.43	46.24	45.45
Average Inventory Full definition →	81.44	83.66	54.45	39.02
Average Assets Full definition →	1,130.01	1,111.98	1,150.92	1,217.86
Average Common Equity Full definition →	609.85	627.05	678.54	701.44

Fold the line items

Columns are period end dates

Stockrow Weekly